Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Filipe Sousa Cardoso has a total of 242 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum ammonia improves early risk stratification beyond West Haven criteria in acute liver failure

    by Filipe S. Cardoso, Prem A. Kandiah, Christopher F. Rose, David Toapanta, Enric Reverter, Rajiv Jalan, William M. Lee, Constantine J. Karvellas

    The prognosis of patients with acute liver failure (ALF) presenting with low-grade hepatic encephalopathy (HE) defined by the West Haven criteria (WHC) is difficult to establish. We studied the association between HE severity, assessed by WHC and serum ammonia, and outcomes across different age groups. Retrospective analysis of the prospective multicentre United States ALF Study Group registry (2000–2016). Exposures were WHC and serum ammonia on day 1 after inclusion. Endpoints were transplant-free survival (TFS) and mortality due to cerebral events on day 21. Findings were validated in a different and more recent (2010–2023) European cohort. Among 1092 patients, the median age was 39 years and 526 (48.2%) had acetaminophen toxicity. On day 1, 968 (88.6%) patients were in the intensive care unit, and 669 (61.3%) were receiving any specific organ support (ventilation, vasopressors, or renal replacement therapy). TFS and cerebral mortality on day 21 were 45.2% and 6.3%, respectively. Patients with hyperammonemia (≥50 µmol/L) on day 1 had lower TFS on day 21 than others, both for WHC grades 1–2 (53.0% vs. 65.2%) and 3–4 (31.8% vs. 60.9%). Higher ammonia on day 1 was independently associated with lower TFS on day 21, irrespective of WHC grade (odds ratio of 0.958 per each 10 µmol/L increment). Ammonia on day 1 of ≥100 µmol/L showed a significant threshold effect for TFS or cerebral mortality on day 21. Patients <40 years had the highest probability of cerebral mortality on day 21. In ALF, serum ammonia may help to define HE and assess prognosis earlier, irrespective of WHC grade. Patients with early serum ammonia of ≥100 µmol/L require optimized monitoring and treatment.

  • Open Access

    Bridging Critically Ill Patients With Cirrhosis to Transplant With Renal Replacement Therapy: A Multicenter Cohort Study

    by Filipe S. Cardoso, Minjee Kim, Beverley Kok, Richard Wunderink, Juan G. Abraldes, Constantine J. Karvellas

    Background & Aims: The efficacy of renal replacement therapy (RRT) in critically ill patients with cirrhosis remains dubious. We aimed to assess the impact of RRT on these patients' outcomes. Methods: Multicenter retrospective cohort study including adult patients with cirrhosis admitted to intensive care units at University of Alberta Hospital (Edmonton, Canada) and Northwestern Memorial Hospital (Chicago, US) from January 2010 to December 2017. Primary exposure was receipt of RRT on ICU days 1 to 3. Fine and Gray multivariable regression with competing endpoints, in‐hospital liver transplant (LT) and mortality, was performed. Results: Among 898 patients, median (IQR) age was 57 (49–64) years and 539 (60.0%) were males. RRT on days 1 to 3 was used in 249 (27.7%) patients. Patients on RRT on days 1 to 3 had higher CLIF‐C‐ACLF scores on days 1 (61 vs. 55, p < 0.001) and 3 (59 vs. 50; p < 0.001) than others. During the hospital stay, 97 (10.8%) patients were transplanted and 296 (33.0%) died. Following adjustment for aetiology, number of extra‐renal organ failures, and year of inclusion, using mortality as competing event, RRT on days 1 to 3 was associated with higher hazard of LT (HR (95% CI) = 1.54 (1.02–2.32); p = 0.039). Conversely, using LT as competing event, RRT on days 1 to 3 was not associated with mortality (HR (95% CI) = 1.15 (0.90–1.47); p = 0.25). Conclusions: Among critically ill patients with cirrhosis, early RRT, while offered more often to the sickest patients, was associated with a higher likelihood of receiving LT, but not with mortality.


  • Open Access

    Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey

    by Claire Bellec, Anea Augé, Sébastien L’HErmite, Romain Moirand, Armand Abergel, Matthew Amstrong, Teresa Antonini, Rodolphe Anty, Marion Khaldi, Aurore Baron, et al.

  • Open Access

    Brain CT Scan Diagnostic and Prognostic Value in Patients With Acute Liver Failure and Cerebral Edema: A Multicenter Cohort Study

    by Filipe S. Cardoso, William M. Lee, Constantine J. Karvellas, U.S. Acute Liver Failure Study Group

    OBJECTIVE: Patients with acute liver failure (ALF) may develop cerebral edema. We aimed to study the CT scan diagnostic and prognostic value among patients with ALF and cerebral edema. DESIGN: International multicenter retrospective cohort. SETTING: U.S. Acute Liver Failure Study Group prospective registry. PATIENTS: Consecutive patients with ALF within the registry from January 1998 to August 2016. INTERVENTIONS: The primary exposure was cerebral edema on CT scan. The primary endpoint was 21-day post-inclusion transplant-free survival (TFS). MEASUREMENTS AND MAIN RESULTS: Among 2108 patients with ALF, 243 (11.5%) had a brain CT scan. Among those 243 patients, 105 (43.2%) had cerebral edema and 11 (4.5%) later developed tonsillar herniation. Patients with cerebral edema on CT scan were younger (36 vs. 46 yr; p < 0.001) and more often females (81.0% vs. 63.8%; p = 0.003), had more acetaminophen-related ALF (61.0% vs. 39.4%; p < 0.001), required more frequently invasive mechanical ventilation on day 1 (73.3% vs. 55.8%; p = 0.005), and had higher maximum days 1–7 model for end-stage liver disease (MELD) score (39 vs. 35; p = 0.002) than others. Following adjustment for confounders (age, acetaminophen toxicity, and severity of disease by MELD), cerebral edema was associated with lower odds of 21-day TFS (adjusted odds ratio = 0.36 [95% CI, 0.18–0.72]; C-statistic = 0.81 [95% CI, 0.75–0.86]; p = 0.003). However, cerebral edema was not associated with selection for liver transplant (22.9% vs. 16.1%; p = 0.18). CONCLUSIONS: In our cohort of patients with ALF, brain CT scan use increased overtime. Among those with a brain CT scan, about two in five had cerebral edema. Cerebral edema on CT scan was independently associated with worse 21-day TFS but did not preclude transplant. Brain CT scan may provide additional diagnostic and prognostic information in selected patients with ALF.


  • Letter to the Editor: Mean arterial pressure as a complex treatment target in patients with cirrhosis and acute kidney injury

    by Filipe S. Cardoso

    An abstract is unavailable. This article is available as a PDF only.

  • Ammonia and urea metabolism in acute liver failure: A multicentre cohort study

    by Filipe S. Cardoso, David Toapanta, Natalia Jimenez, Pedro Fidalgo, António Figueiredo, Miriam Valdivieso, Nuno Germano, Jody A. Rule, William M. Lee, Juan G. Abraldes, et al.

    Background & Aims: Ammonia is metabolized into urea in the liver. In acute liver failure (ALF), ammonia has been associated with survival. However, urea variation has been poorly studied.Methods: Observational cohort including ALF patients from Curry Cabral Hospital (Lisbon, Portugal) and Clinic Hospital (Barcelona, Spain) between 10/2010 and 01/2023. The United States ALF Study Group cohort was used for external validation. Primary exposures were serum ammonia and urea on ICU admission. Primary endpoint was 30‐day transplant‐free survival (TFS). Secondary endpoint was explanted liver weight.Results: Among 191 ALF patients, median (IQR) age was 46 (32; 57) years and 85 (44.5%) were males. Overall, 86 (45.0%) patients were transplanted and 75 (39.3%) died. Among all ALF patients, following adjustment for age, sex, body weight, and aetiology, higher ammonia or lower urea was independently associated with higher INR on ICU admission (p < .009). Among all ALF patients, following adjustment for sex, aetiology, and lactate, higher ammonia was independently associated with lower TFS (adjusted odds ratio (95% confidence interval [CI]) = 0.991 (0.985; 0.997); p = .004). This model predicted TFS with good discrimination (area under receiver operating curve [95% CI] = 0.78 [0.75; 0.82]) and reasonable calibration (R2 of 0.43 and Brier score of 0.20) after external validation. Among transplanted patients, following adjustment for age, sex, actual body weight, and aetiology, higher ammonia (p = .024) or lower (p < .001) urea was independently associated with lower explanted liver weight.Conclusions: Among ALF patients, serum ammonia and urea were associated with ALF severity. A score incorporating serum ammonia predicted TFS reasonably well.


  • Open Access

    Carbapenem-Resistant Enterobacteriaceae Colonization or Infection Was Not Associated with Post-Liver Transplant Graft Failure: An Observational Cohort Study

    by João Caria, Ana C. Gonçalves, Gonçalo Cristóvão, Maria Carlos, Sara Magalhães, Vasco Almeida, Fernanda Moreno, Élia Mateus, Hélder Pinheiro, Diana Póvoas, et al.

    Introduction: Carbapenem-resistant Enterobacteriaceae (CRE) epidemiology among liver transplant (LT) recipients is variable. We studied the impact of CRE colonization and infection on LT recipients’ outcomes. Methods: This observational cohort study included consecutive adult LT recipients between January 2019 and December 2020 at Curry Cabral Hospital, Lisbon, Portugal. Primary exposures were CRE colonization (rectal swabs under a screening program) and infection within 1 year of index LT. Primary endpoint was graft failure within 1 year of the index LT. Results: Among 209 patients, the median (interquartile range [IQR]) age was 57 (47–64) years and 155 (74.2%) were male. CRE colonization was identified in 28 (13.4%) patients during the first year posttransplant (median [IQR] number of rectal swabs per patient of 4 [2–7]). CRE resistance genes identified were OXA48 in 8 (3.6%) patients, KPC in 19 (67.9%) patients, and VIM in 1 (3.6%) patient. Any bacterial/fungal and CRE infections were diagnosed in 88 (42.1%) and 6 (2.9%) patients, respectively, during the first year posttransplant. After adjusting for confounders, neither CRE colonization (aOR [95% CI] = 1.83 [0.71–4.70]; p = 0.21) nor infection (aOR [95% CI] = 1.35 [0.17–11.06]; p = 0.78) was associated with graft failure within 1 year of index LT. Discussion/Conclusion: Under a screening program, CRE colonization and infection prevalence was low and neither was associated with graft failure.

  • Referral for liver transplant following acute variceal bleeding: a multicenter cohort study

    by Sofia Bragança, Marta Ramos, Sara Lopes, Gonçalo Alexandrino, Milena Mendes, Rui Perdigoto, João Coimbra, Hugo P. Marques, Filipe S. Cardoso

    Objectives: Referral for liver transplant (LT) following acute variceal bleeding (AVB) varies widely. We aimed to characterize and assess its impact on clinical outcomes. Methods: Observational retrospective cohort including cirrhosis patients with AVB from 3 hospitals in Lisbon, Portugal, from 2018 to 2019. Primary exposure was referral for LT and primary endpoint was all-cause mortality within 2 years of index hospital admission. Results: Among 143 patients, median (IQR) age was 59 (52–72) years and 90 (62.9%) were males. Median (IQR) MELDNa scores on hospital admission and discharge were 15 (11–21) and 13 (10–16), respectively. Overall, 30 (21.0%) patients were assessed for LT, 13 (9.1%) prior to and 17 (11.9%) within 2 years of hospital admission. Overall, 58 (40.6%) patients had at least one potential contra-indication for transplant. LT was performed in 3 (2.1%) patients (among 5 listed). Overall, 34 (23.8%) and 62 (43.4%) patients died at 6 weeks and 2 years post hospital admission, respectively. Following adjustment for confounders, referral for LT was associated with lower 2-year mortality (aHR (95% CI) = 0.20 (0.05–0.85)). Conclusion: In a multicenter cohort of cirrhosis patients with AVB, less than a quarter underwent formal LT evaluation. Improved referral for LT following AVB may benefit cirrhosis patients’ longer-term mortality.


  • Open Access

    Long-Term Follow-Up of Kidney Function after Acute Liver Failure or Acute Liver Injury: A Cohort Study

    by Pedro Fidalgo, Pedro Póvoa, Nuno Germano, Constantine J. Karvellas, Filipe S. Cardoso

    Introduction: Acute liver failure (ALF) is a rare disease with high mortality. Acute kidney injury (AKI) following ALF is frequent. We assessed AKI impact on long-term kidney function among ALF survivors. Methods: Observational cohort study including consecutive adult (age ≥16 years) patients with ALF or acute liver injury (ALI) admitted to a Portuguese tertiary center intensive care unit (ICU) between October 2013 and February 2020. KDIGO criteria were used to define AKI and chronic kidney disease (CKD). Primary outcome was the estimated glomerular filtration rate (eGFR), defined by the Chronic Kidney Disease Epidemiology Collaboration formula, at least 1 year after index ICU admission. Results: Among 104 patients with ALF (n = 74) or ALI (n = 30), mean (SD) age was 43.7 (18.0) years, and 44 were male. Among all patients (n = 104), following adjustment for age and SOFA score, AKI during the first 7 ICU days (n AKI = 57 and n renal replacement therapy [RRT] = 32) was independently associated with all-cause mortality (adjusted HR [95% CI] 11.61 [1.49–90.34]; p = 0.019). Among hospital survivors with long-term kidney function available (n = 56), median (interquartile range) >1 year eGFR was 95.3 (75.0–107.7) mL/min/1.73 m2 (mean [SD] follow-up of 3.1 [1.6] years). Among these hospital survivors, following adjustment for baseline eGFR, AKI during the first 7 ICU days (n AKI = 19 and n RRT = 10) was not associated with >1 year eGFR (p = 0.15). At least 1 year after index ICU admission, 5 patients developed CKD, none RRT-dependent. Conclusions: Among ALF or ALI survivors, AKI was not associated with significant long-term loss of kidney function.